Meet Scientific Advisory Panel members
...who attended the March meeting on proteins


Professor Antony Basten AO is Chairman of Apollo Life Sciences Scientific Advisory Panel, and also one of the world's leading clinician scientists. Professor Basten is an Emeritus Professor at the University of Sydney, a Senior Principal Research Fellow at the Garvan Institute and, until recently, was the foundation Executive Director of the Centenary Institute of Cancer Medicine & Cell Biology. He is also a Fellow of the Australian Academies of Science and Technological Sciences and Engineering and a Florey lecturer of the Royal Society, London, as well as the chief Commonwealth advisor on the medical and scientific aspects of HIV/AIDS. His awards include a Centenary Medal from the Prime Minister of Australia and the inaugural Wellcome Australia Medal for distinguished discovery and its demonstrated use.

Professor Alan Trounson AO is one of the leading figures in Australian and international medicine. A pioneer of in vitro fertilisation treatment, he is the scientific director of Monash IVF and a director of Monash University's Immunology and Stem Cell Laboratories. He is also a member of Australia's Scientific Advisory Panel. Over the past few years, Professor Trounson has become known as a champion of stem cell research. Professor Trounson has received numerous appointments and accolades throughout his academic career, and has been particularly recognised for his part in helping couples have children. Professor Trounson's current research focus is human embryonic stem cells and their potential use in the treatment of inflammatory lung disease and cystic fibrosis.

Professor Peter Schofield heads one of the largest centres of research on the brain and nervous system in Australia, the Prince of Wales Medical Research Institute. He is also a major contributor to the stem cell debate. Peter appointments in both medicine and biotechnology at the University of New South Wales. He is also a member of the Pharmaceutical Subcommittee of the Australian Drug Evaluation Committee. Peter's research has been recognised by many awards. His interests focus on understanding how signalling in the brain occurs, through studies of neurotransmitter receptors, and identifying genes that lead to disorders such as manic depressive illness and Alzheimer's disease.


Professor Nick Hunt directs the Institute for Biomedical Research at the University of Sydney, heading a lab that sits in the Medical Foundation Building, which is the strategic focus of genomics developments at the University of Sydney. He is a leading immunopathologist, and has a particular research interest in infectious diseases, especially malaria. He has many awards including the 2005 Dintenfass Prize from the Rebecca L Cooper Foundation for the best research grant proposal


Professor Roger Daly Heads the Signal Transduction Group in the Cancer Research Program at the Garvan Institute of Medical Research. He has particular interests in cancer and anti-cancer drugs, as well as working closely with the Diabetes and Obesity program on regulation of insulin signalling. He holds joint appointments in the department of Medicine at St Vincent's Hospital Clinical School and the University of New South Wales. He is an NH&MRC Principal Research Fellow.
For further information, visit:
Find out more about the Scientific Advisory Panel
Find out more about Apollo's hcx proteins
back to Newsletter
  
click to subscribe  |  
www.apollolifescience.com
 
Apollo Life Sciences Limited  ASX: AOP
Level 1, 147 Queen Street Beaconsfield NSW 2015 Australia